Smith+Nephew announces the launch of its new TRIGEN MAX Tibia Nailing System for stable and unstable fractures of the tibia, including the shaft. It is the only system to now offer trauma surgeons the choice of side-specific nails for anatomic screw trajectories, which help to optimize fragment fixation and minimize soft tissue irritation with headless and low-profile screw options.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNN:
- Smith & Nephew names Ajay Dhankhar chief corporate development, strategy officer
- Smith & Nephew partners with Standard Health
- Smith+Nephew Appoints New Non-Executive Director
- Smith & Nephew Announces Managerial Stock Transactions
- Smith & Nephew price target raised to 1,450 GBp from 1,425 GBp at Citi